Imugene (ASX:IMU) granted two FDA approvals for concurrent clinical trials
Imugene (ASX:IMU) receives US FDA approval to initiate two clinical trial of its immunotherapy candidate, HER-Vaxx.
Australian children aged five to 11 to receive Pfizer from January 10
Australian's aged five to 11 will be able to receive Pfizer from early next year, the…
Petrol prices hit 7-year high in October, up 25 per cent year-on-year
Petrol prices hit a seven year high in October, according to new figures from the Australian…
Australia will not need coal-fired power by 2043: AEMO
Australia can phase out coal-fired power by 2043, according to the energy market operator in a…
Fortescue Metals Group’s (ASX:FMG) Elizabeth Gaines steps down as CEO, moves to green hydrogen
Fortescue Metals Group's (ASX:FMG) CEO Elizabeth Gains steps down from her role as CEO to become…
“A widespread system failure”: ASIC sues ANZ (ASX:ANZ) again
The corporate regulator takes legal action against ANZ Bank (ASX:ANZ) for failing to pass on financial…
Protestors attack Rio Tinto’s (ASX:RIO) planned lithium mine in Serbia
Thousands of people have taken to the streets of Serbia to protest again Rio Tinto's (ASX:RIO)…
Metaverse hopeful Animoca Brands flags $16b in crypto assets in latest unaudited financial results
Formerly-listed blockchain juggernaut Animoca Brands has released its latest unaudited financial results for the nine months…
ACCC okays Sydney Aviation Alliance’s proposed acquisition of Sydney Airport (ASX:SYD)
The ACCC will not challenge the proposed $23.6 billion takeover of Sydney Airport (ASX:SYD) by Sydney…
Santos (ASX:STO) to sell a 12.5pc interest in Barossa to JERA
Oil and gas giant Santos (ASX:STO) has signed a binding sale and purchase agreement (SPA) to…